The 6th consortium meeting of NOMAD took place in Groningen, NL

🦷 6th NOMAD Consortium Meeting – Updates from Groningen, Netherlands

On June 18–20, 2024, the NOMAD consortium gathered in Groningen, Netherlands, for the 6th official project meeting, hosted by our partner UMCG (University Medical Center Groningen) in the Netherlands.

The two and a half day event brought together all 10 partners, in person and online. We reflected on key milestones and looked ahead to the next stages of our mission: developing the next generation of smart dental implants that actively prevent peri-implant infections.

🔍 Day 1 – IP Workshop: Exploring Innovation Beyond the Lab

We opened the meeting with an interactive, hands-on Intellectual Property (IP) Workshop prepared by the Atrineo team. NOMAD teams explored strategies for identifying relevant patent landscapes using AI-powered tools to support innovation planning and scanning what is the latest in their respective domains.

The session helped link the gap between science and commercialization, offering practical guidance for how NOMAD’s scientific advances can lead to protected, impactful products.

🧪 Day 2 – Partner Updates and Cross-Disciplinary Collaboration

The second day focused on scientific and technical progress, with updates from multiple partners:

Anthogyr presented developments in the design and prototyping of advanced implant components.

CNRS and École Centrale de Lyon led sessions on biomaterial characterization and progress in WP1, ensuring that NOMAD’s research remains at the forefront of functional surface innovation.

KU Leuven shared key in vitro testing results, highlighting how NOMAD-modified surfaces enhance tissue integration and resist bacterial colonization.

Croom Medical and Glantreo updated the consortium on their additive manufacturing processes and implant architecture.

UCM (Complutense University of Madrid) provided insights into the plans for preclinical models for peri-implantitis, outlining how their in vivo testing planning and how  all preparations should fall into place for pre-clinical readiness.

🗣️ Day 3 – Impact, Translation & Strategy

The final day of the meeting shifted focus to impact, communication, and clinical translation:

The teams from UCM and UMCG presented results from advanced co-culture models, showing how NOMAD technologies behave in complex infection scenarios and support tissue integration during biofilm formation.

Atrineo AG delivered updates on IP landscape, market intelligence, and communication activities, highlighting tools to support exploitation and engagement with stakeholders.

KU Leuven, in collaboration with all partners, led a discussion on how to bridge lab results with clinical application, preparing for future preclinical studies and identifying paths to patient benefit.

A warm thank you to UMCG for hosting this dynamic and productive meeting.

🚀 Looking Ahead

With in vivo testing scheduled for autumn 2025 and regulatory planning advancing, the NOMAD project enters a pivotal phase. We remain focused on transforming fundamental research into dental implant solutions that truly improve patient outcomes.

👉 Stay connected with us and follow NOMAD on LinkedIn to see how we’re shaping the future of dental health.